One regulatory strategy for every market you intend to file in
Strategic regulatory consulting from an in-house team with direct FDA and DCGI expertise, designing your program to EMA, PMDA, MFDS and NMPA standards — from preclinical development through market authorization.
eteraflex connects supports global pharmaceutical, biotechnology, and medical-device companies with integrated regulatory strategy, expert submissions, and compliant execution across the markets you file in — with India’s Subject Expert Committee (SEC) anticipated from the start.
Regulatory excellence across the product lifecycle
We deliver end-to-end regulatory strategy for pharmaceuticals, biologics, and medical devices, combining in-house FDA and DCGI expertise with design-to-standard for the EMA, PMDA, MFDS and NMPA. From preclinical planning and clinical development through approvals and post-market compliance, we help you achieve compliant, audit-ready market access at every stage.
Preclinical planning
Clinical development
Approvals
Post-market compliance
Our Core Offerings
Comprehensive regulatory solutions for pharmaceutical, biologics & medical-device programs
Our services cover the entire product lifecycle — from strategic planning and dossier preparation to compliance management and submissions.
Strategic Regulatory Development
Dedicated regulatory leadership guiding assets from early feasibility through market entry
Multi-Region Filing Strategy
One development plan designed to hold across the FDA, EMA, PMDA, MFDS, NMPA and India’s DCGI.
Clinical Trial Regulatory Support
Trial protocol filings, ethics approvals, and study closeout, with SEC preparation and Sugam submission managed in-house.
CMC-Aligned Submissions
Dossiers built with the CMC and quality story aligned to the filing.
Medical Device Regulatory Expertise
Classification pathways, CERs, PMCF planning, and licensing.
Authority Engagement & Representation
Direct representation in CDSCO/SEC meetings, advisory-panel preparation, and strategic advocacy.
Our Regulatory Capabilities
A structured, transparent, milestone-driven approach designed to reduce risk and ensure compliance at every stage.
Preclinical & Regulatory Planning
In-house FDA + DCGI regulatory expertise, designing to EMA, PMDA, MFDS and NMPA standards.
Regulatory Feasibility
valuate risks, requirements, and pathway options to build a clear regulatory roadmap.
Dossier Development & Submission
high-quality documentation, rigorous review, and end-to-end submission management.
CDSCO / SEC Engagement
coordinate directly with authorities, prepare for the Subject Expert Committee, and address queries.
Post-Approval Compliance
amendments, safety reporting, renewals, and ongoing compliance.
Technology & Quality
Regulatory intelligence built for compliance
We combine technology-enabled workflows with proven regulatory expertise to streamline submissions and strengthen compliance.
Technology
- Standardized, submission-ready dossier templates
- Real-time submission tracking and milestone visibility
- Quality review workflows
- Documentation accuracy and completeness checks
- Structured timeline planning for clearer program visibility
Quality & Compliance
- Inspection-ready documentation and regulatory compliance
- Risk-based oversight throughout the submission lifecycle
- CAPA management — structured corrective and preventive action
- Reliable, predictable regulatory execution
- Continuous process and documentation improvement
Ready to Move Your Clinical Program Forward?
Connect with our regulatory, clinical, and operations experts to discuss your goals and build the right strategy for success across the markets you file in.
